Iain Wilkie
Stock Analyst at Morgans
(0.13)
# 4,315
Out of 4,408 analysts
141
Total ratings
29%
Success rate
-12.9%
Average return
Main Sectors:
Stocks Rated by Iain Wilkie
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: PME Pro Medicus Limited | Maintained: Buy | $210.00 | $163.98 | +28.06% | 27 | Jun 2, 2026 | |
| ASX: NUZ Neurizon Therapeutics Limited | Maintained: Buy | $0.28 → $0.20 | $0.064 | +212.50% | 9 | May 28, 2026 | |
| ASX: MAP Microba Life Sciences Limited | Maintained: Buy | $0.29 → $0.15 | $0.045 | +233.33% | 8 | May 14, 2026 | |
| ASX: M7T Mach7 Technologies Limited | Maintained: Buy | $0.76 → $0.44 | $0.335 | +31.34% | 8 | Apr 27, 2026 | |
| ASX: EIQ Echo IQ Limited | Maintained: Buy | $1.30 | $1.20 | +8.33% | 1 | Apr 16, 2026 | |
| ASX: SOM SomnoMed Limited | Maintained: Buy | $0.99 | $0.56 | +76.79% | 19 | Mar 2, 2026 | |
| ASX: IME ImExHS Limited | Maintained: Buy | $0.35 → $0.50 | $0.38 | +31.58% | 13 | Mar 2, 2026 | |
| ASX: CUV Clinuvel Pharmaceuticals Limited | Maintained: Buy | $14.00 → $13.00 | $9.44 | +37.71% | 6 | Feb 27, 2026 | |
| ASX: NAN Nanosonics Limited | Maintained: Buy | $5.00 → $4.00 | $3.19 | +25.39% | 7 | Feb 25, 2026 | |
| ASX: PIQ Proteomics International Laboratories Ltd | Downgraded: Sell | $0.43 | $0.115 | +273.91% | 7 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.58 → $0.24 | $0.004 | n/a | 8 | Sep 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.22 → $0.29 | $0.031 | n/a | 4 | Sep 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $1.28 → $0.78 | $0.155 | n/a | 14 | Mar 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.43 | $0.10 | n/a | 3 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.31 → $1.24 | $0.25 | n/a | 4 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.89 → $1.64 | $0.013 | n/a | 3 | Feb 16, 2022 |
Pro Medicus Limited
Jun 2, 2026
Maintained: Buy
Price Target: $210.00
Current: $163.98
Upside: +28.06%
Neurizon Therapeutics Limited
May 28, 2026
Maintained: Buy
Price Target: $0.28 → $0.20
Current: $0.064
Upside: +212.50%
Microba Life Sciences Limited
May 14, 2026
Maintained: Buy
Price Target: $0.29 → $0.15
Current: $0.045
Upside: +233.33%
Mach7 Technologies Limited
Apr 27, 2026
Maintained: Buy
Price Target: $0.76 → $0.44
Current: $0.335
Upside: +31.34%
Echo IQ Limited
Apr 16, 2026
Maintained: Buy
Price Target: $1.30
Current: $1.20
Upside: +8.33%
SomnoMed Limited
Mar 2, 2026
Maintained: Buy
Price Target: $0.99
Current: $0.56
Upside: +76.79%
ImExHS Limited
Mar 2, 2026
Maintained: Buy
Price Target: $0.35 → $0.50
Current: $0.38
Upside: +31.58%
Clinuvel Pharmaceuticals Limited
Feb 27, 2026
Maintained: Buy
Price Target: $14.00 → $13.00
Current: $9.44
Upside: +37.71%
Nanosonics Limited
Feb 25, 2026
Maintained: Buy
Price Target: $5.00 → $4.00
Current: $3.19
Upside: +25.39%
Proteomics International Laboratories Ltd
Feb 2, 2026
Downgraded: Sell
Price Target: $0.43
Current: $0.115
Upside: +273.91%
Sep 2, 2024
Maintained: Buy
Price Target: $0.58 → $0.24
Current: $0.004
Upside: n/a
Sep 1, 2022
Maintained: Buy
Price Target: $0.22 → $0.29
Current: $0.031
Upside: n/a
Mar 9, 2022
Downgraded: Sell
Price Target: $1.28 → $0.78
Current: $0.155
Upside: n/a
Feb 28, 2022
Maintained: Buy
Price Target: $1.43
Current: $0.10
Upside: n/a
Feb 24, 2022
Maintained: Buy
Price Target: $1.31 → $1.24
Current: $0.25
Upside: n/a
Feb 16, 2022
Maintained: Buy
Price Target: $1.89 → $1.64
Current: $0.013
Upside: n/a